Records containing: Multiple System Atrophy
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study results posted · 2026-08-07Effect of Midodrine vs Abdominal Compression on Cardiovascular Risk Markers in Autonomic Failure Patients
-
CLINICAL_TRIALS study record update · 2026-06-04Interventional, Randomized, Double-blind, Placebo-controlled, Optional Open-label Extension Trial of Lu AF82422 in Participants With Multiple System Atrophy
-
CLINICAL_TRIALS study results posted · 2026-06-02A Randomized, Double-blind, Placebo-Controlled, Phase 2 Study to Evaluate the Efficacy, Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Intravenous TAK-341 in Subjects With Multiple System Atrophy
-
CLINICAL_TRIALS study record update · 2026-04-27Effect of Comprehensive Swallowing Rehabilitation in Patients With Multiple System Atrophy: A Randomized Controlled Trial
-
CLINICAL_TRIALS study record update · 2026-04-27A Phase 1 Study to Assess the Safety, Tolerability, and Pharmacokinetics of ION464 Administered Intrathecally to Adults With Multiple System Atrophy
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2026-04-23A Double-Blind, Placebo-Controlled, Multi-Center, Phase II, Dose Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of YA-101 in Subjects With Multiple System Atrophy
-
CLINICAL_TRIALS study record update · 2026-04-23Interventional, Randomized, Double-blind, Placebo-controlled, Optional Open-label Extension Trial of Lu AF82422 in Participants With Multiple System Atrophy
-
CLINICAL_TRIALS study record update · 2026-04-20Clinical Laboratory Evaluation of Chronic Autonomic Failure
-
CLINICAL_TRIALS study record update · 2026-04-17"An Intermediate Size Patient Population Expanded Access Protocol to Evaluate the Safety and Efficacy of Allogeneic HB-adMSCs for the Treatment of Multiple System Atrophy."
-
CLINICAL_TRIALS study record update · 2026-04-17An Open-Label Extension, Multi-Centered, Phase 2 Trial to Describe the Safety and Efficacy of TEV-56286 (Emrusolmin) in Participants With Multiple System Atrophy
-
CLINICAL_TRIALS study record update · 2026-04-17A Multi-centered, Double-blind, Randomized, Placebo-controlled, Parallel Group Phase 2 Study of TEV-56286 for the Treatment of Patients With Multiple System Atrophy (TOPAS-MSA)
-
CLINICAL_TRIALS study record update · 2026-04-17Pain and Autonomic Symptoms in Parkinson's Disease and Atypical Parkinsonisms: Identification of Predictive Patterns of Rehabilitation Outcome and Evaluation of the Impact on Quality of Life
-
CLINICAL_TRIALS study record update · 2026-04-15Post-Trial Access to ATH434 for Patients With Multiple System Atrophy
-
CLINICAL_TRIALS study record update · 2026-04-09Efficacy and Safety of Butylphthalide in the Treatment of Multiple System Atrophy（ENMSA）: A Multicenter, Randomised, Double-blinded, Placebo-controlled Trial
-
CLINICAL_TRIALS study record update · 2026-04-08Evaluate the Long-term (3 Months) Efficacy of L-threo DOPS (DroxiDopa) on Orthostatic Hypotension Symptoms and Other Non-motor Symptoms in Patients With Multiple System Atrophy (MSA). Comparative Study Versus Placebo
-
CLINICAL_TRIALS study record update · 2026-04-07A Phase 1 Study to Assess the Safety, Tolerability, and Pharmacokinetics of ION464 Administered Intrathecally to Adults With Multiple System Atrophy
-
CLINICAL_TRIALS study record update · 2026-04-07Hemodynamic Effects of Positive Airway Pressure to Treat Supine Hypertension and Improve Neurogenic Orthostatic Hypotension
-
CLINICAL_TRIALS study record update · 2026-04-06The Swedish BioFINDER 2 Study
-
CLINICAL_TRIALS study record update · 2026-04-01A Phase I Study of the Feasibility and Safety of SuraL nervE Tissue Grafting to the Substantia nigrA in Patients With Synucleinopathies (LEAP)
-
CLINICAL_TRIALS study record update · 2026-03-30Expansion Study of ALT001 in Patients With Multiple System Atrophy
-
CLINICAL_TRIALS study record update · 2026-03-16[18F]F-DOPA Imaging in Patients With Autonomic Failure
-
CLINICAL_TRIALS study record update · 2026-03-16A Phase 1b Clinical Trial of UB-312 in Patients With Synucleinopathies
-
CLINICAL_TRIALS study record update · 2026-03-13Reduction in Splanchnic Capacitance Contributes to Sympathetically Dependent Hypertension in Autonomic Aim 1 of Rare Diseases Clinical Research Network (RDCRN) Project 2
-
CLINICAL_TRIALS study record update · 2026-03-10A Phase 2a, Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Safety, Tolerability, and Pharmacokinetics of Multiple Ascending Dosing of Exidavnemab in Patients With Mild to Moderate Parkinson's Disease on Stable Symptomatic Parkinson's Disease Medication and in Patients With Multiple System Atrophy
-
CLINICAL_TRIALS study record update · 2026-03-06Building Online Community to Improve Patient and Caregiver Outcomes in Parkinson Disease, Lewy Body Dementia and Related Disorders